OAKLAND, N.J. — Findings from a recent study are highlighting the clinical efficacy of AEYE Health and Topcon Healthcare’s artificial intelligence (AI) solutions for autonomous diabetic retinopathy screening. Together, Topcon’s NW500 non-mydriatic retinal camera and AEYE’s Diagnostic Screening (AEYE-DS) set a new standard for accessible, on-the-spot patient care.
Read more here.